Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Interleukin-2 × 30 days × Clear all

Sponsor

Conditions

Recurrence 2 Ovarian Neoplasms 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Sarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma in Situ 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 6 fludarabine 6 Whole-Body Irradiation 5 Mycophenolic Acid 4 asciminib 3 Mesna 3 Melphalan 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Dasatinib 3 nilotinib 2 bosutinib 2 Tacrolimus 2 Stem Cell Transplantation 2 Cyclosporine 2 Busulfan 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ponatinib 1 blinatumomab 1 aldesleukin 1 Thiotepa 1 Succimer 1 Peripheral Blood Stem Cell Transplantation 1 Pentetic Acid 1 Patient Reported Outcome Measures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡